Hedge Fund - Sarissa Capital Management
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $42,995,906 | 19.29% | 303,151 | $144.87 |
| 2 | 2025 - Q3 (2025-09-30) | $42,556,337 | 23.59% | 303,151 | $135.50 |
| 3 | 2025 - Q2 (2025-06-30) | $38,103,049 | 24.68% | 303,151 | $114.68 |
| 4 | 2025 - Q1 (2025-03-31) | $34,188,230 | 22.1% | 309,116 | $126.68 |
| 5 | 2024 - Q4 (2024-12-31) | $42,194,334 | 13.06% | 309,116 | $123.68 |
| 6 | 2024 - Q3 (2024-09-30) | $47,295,851 | 11.75% | 410,483 | $137.09 |
| 7 | 2024 - Q2 (2024-06-30) | $56,511,195 | 9.53% | 410,483 | $137.14 |
| 8 | 2024 - Q1 (2024-03-31) | $47,779,074 | 8.35% | 346,426 | $136.57 |
| 9 | 2023 - Q4 (2023-12-31) | $61,927,200 | 9.54% | 470,000 | $115.11 |
| 10 | 2023 - Q3 (2023-09-30) | $41,175,000 | 5.54% | 366,000 | $105.30 |
| 11 | 2023 - Q2 (2023-06-30) | $21,811,590 | 2.17% | 231,300 | $97.71 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center